Company Analysis

Nephros, Inc. (NEPH)

Nasdaq: NEPH · Surgical & Medical Instruments & Apparatus · South Orange, NJ · filing with the SEC since 2002
Grade6.2
◀ Past 4.9● Present 6.8▶ Future 6.5

Who runs Nephros, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Banks Robert R. Jr.
President and CEO. First filing May 2023, latest Mar 25, 2026, 3 filings in all.
Officers reporting now
2
of 10 people with a filing in the last fifteen months
Directors reporting now
8
21 people on the record since 2007
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Banks Robert R. Jr.President and CEOMay 2023Mar 25, 2026none
Krandel JudyChief Financial OfficerNov 2023Mar 25, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Amron Arthur HdirectorOct 2007Nov 12, 2026none
Spandow Oliver J.directorAug 2018Nov 12, 2026none
Amron Holdings LLCdirectorSep 2026Sep 16, 2026none
Davidson Charles EdirectorOct 2007Sep 16, 2026none
Jacobs JosephdirectorOct 2007Sep 16, 2026none
Wexford Capital LPdirectorOct 2007Sep 16, 2026none
Wexford Gp LLCdirectorMar 2011Sep 16, 2026none
Nettis Lisa MariedirectorJul 2025Nov 13, 2025none
Earlier names on the record11, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton NEPH · research, not advice